Enveric Biosciences, Inc.
General ticker "ENVB" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $25.1M (TTM average)
Enveric Biosciences, Inc. does not follow the US Stock Market performance with the rate: -10.4%.
Estimated limits based on current volatility of 3.8%: low 5.71$, high 6.16$
Factors to consider:
- Total employees count: 7 as of 2023
- Top business risk factors: Economic downturns and volatility, Labor/talent shortage/retention, Development delays and partner dependencies, Cybersecurity threats, Insurance risks
- Current price 74.7% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [24.16$, 91.38$]
- 2025-12-31 to 2026-12-31 estimated range: [11.01$, 43.21$]
Financial Metrics affecting the ENVB estimates:
- Negative: with PPE of -1.5 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -313.25 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: -0.75 < Inventory ratio change, % of 0
- Negative: negative Industry operating income (median)
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term ENVB quotes
Long-term ENVB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $27.42MM | $16.45MM | $9.63MM |
| Operating Income | $-27.42MM | $-16.45MM | $-9.63MM |
| Non-Operating Income | $7.46MM | $-0.81MM | $0.07MM |
| R&D Expense | $8.03MM | $7.25MM | $2.84MM |
| Income(Loss) | $-19.96MM | $-17.26MM | $-9.57MM |
| Taxes | $-1.49MM | $0.03MM | $0.01MM |
| Profit(Loss)* | $-18.50MM | $-0.02MM | $-9.57MM |
| Stockholders Equity | $14.67MM | $1.96MM | $1.59MM |
| Assets | $19.55MM | $4.30MM | $3.08MM |
| Operating Cash Flow | $-17.15MM | $-14.09MM | $-7.73MM |
| Capital expenditure | $0.58MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $-0.58MM | $0.01MM | $0.00MM |
| Financing Cash Flow | $18.18MM | $-1.34MM | $7.67MM |
| Earnings Per Share** | $-87.85 | $-0.08 | $-228.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.